166 related articles for article (PubMed ID: 25979842)
21. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
[TBL] [Abstract][Full Text] [Related]
22. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
23. shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells.
Park YS; Huh JW; Lee JH; Kim HR
Oncol Rep; 2012 Feb; 27(2):339-46. PubMed ID: 22076607
[TBL] [Abstract][Full Text] [Related]
24. Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway.
Ahn HJ; Kim G; Park KS
Biochem Biophys Res Commun; 2013 Aug; 437(4):557-64. PubMed ID: 23850691
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase.
Kuo YC; Su CH; Liu CY; Chen TH; Chen CP; Wang HS
Int J Cancer; 2009 Jun; 124(11):2568-76. PubMed ID: 19243022
[TBL] [Abstract][Full Text] [Related]
26. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
[TBL] [Abstract][Full Text] [Related]
27. Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity.
Chaudhary F; Lucito R; Tonks NK
Biochem J; 2015 Jan; 465(1):89-101. PubMed ID: 25287652
[TBL] [Abstract][Full Text] [Related]
28. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
[TBL] [Abstract][Full Text] [Related]
29. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
30. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
Azijli K; Yuvaraj S; Peppelenbosch MP; Würdinger T; Dekker H; Joore J; van Dijk E; Quax WJ; Peters GJ; de Jong S; Kruyt FA
J Cell Sci; 2012 Oct; 125(Pt 19):4651-61. PubMed ID: 22797920
[TBL] [Abstract][Full Text] [Related]
31. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
[TBL] [Abstract][Full Text] [Related]
32. TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway.
Meng X; Cai C; Wu J; Cai S; Ye C; Chen H; Yang Z; Zeng H; Shen Q; Zou F
Cancer Lett; 2013 Jun; 333(1):96-102. PubMed ID: 23353055
[TBL] [Abstract][Full Text] [Related]
33. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
[TBL] [Abstract][Full Text] [Related]
34. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
35. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
[TBL] [Abstract][Full Text] [Related]
36. Regulation of CD44 expression by tumor necrosis factor-α and its potential role in breast cancer cell migration.
Li J; Zha XM; Wang R; Li XD; Xu B; Xu YJ; Yin YM
Biomed Pharmacother; 2012 Mar; 66(2):144-50. PubMed ID: 22386367
[TBL] [Abstract][Full Text] [Related]
37. A link between two tumorigenic proteins, CD44 and p21WAF1: CD44 increases phorbol ester-induced expression of p21WAF1 by stabilizing its mRNA and extending protein half-life.
Lindner C; Urbánek P; Pavelka B; Hartmann M; Herrlich P
FEBS Lett; 2013 Aug; 587(16):2698-704. PubMed ID: 23856463
[TBL] [Abstract][Full Text] [Related]
38. Amino-terminal fragments of laminin γ2 chain stimulate migration of metastatic breast cancer cells by interacting with CD44.
Sato H; Higashi S; Miyazaki K
Clin Exp Metastasis; 2015 Jun; 32(5):405-15. PubMed ID: 25990436
[TBL] [Abstract][Full Text] [Related]
39. CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.
Xu H; Wu K; Tian Y; Liu Q; Han N; Yuan X; Zhang L; Wu GS; Wu K
Int J Oncol; 2016 Oct; 49(4):1343-50. PubMed ID: 27499099
[TBL] [Abstract][Full Text] [Related]
40. Cyr61 as mediator of Src signaling in triple negative breast cancer cells.
Sánchez-Bailón MP; Calcabrini A; Mayoral-Varo V; Molinari A; Wagner KU; Losada JP; Ciordia S; Albar JP; Martín-Pérez J
Oncotarget; 2015 May; 6(15):13520-38. PubMed ID: 25980494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
